Medtronic Completes Acquisition of CathWorks

Medtronic has completed the acquisition of CathWorks, a medical devices business in the cardiovascular technology space, for $585 million. Medtronic acquisitions strengthen its cardiovascular disease portfolio by adding CathWorks’ advanced cardiac imaging and interventional analytics used in catheter-based procedures. CathWorks acquisition supports Medtronic’s strategy to improve diagnosis and treatment planning for patients with coronary artery disease, aligning with Medtronic’s innovation roadmap in medical devices. The merger acquisition is a strategic acquisition by a strategic buyer, classified as healthcare M&A and completed as a closed deal.